As of 2025-07-22, the Intrinsic Value of Lyka Labs Ltd (LYKALABS.NS) is 40.38 INR. This LYKALABS.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 113.72 INR, the upside of Lyka Labs Ltd is -64.50%.
The range of the Intrinsic Value is 31.87 - 54.25 INR
Based on its market price of 113.72 INR and our intrinsic valuation, Lyka Labs Ltd (LYKALABS.NS) is overvalued by 64.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 31.87 - 54.25 | 40.38 | -64.5% |
| DCF (Growth 10y) | 56.79 - 92.74 | 70.55 | -38.0% |
| DCF (EBITDA 5y) | 79.42 - 99.07 | 88.07 | -22.6% |
| DCF (EBITDA 10y) | 101.59 - 134.85 | 116.25 | 2.2% |
| Fair Value | 56.15 - 56.15 | 56.15 | -50.62% |
| P/E | 36.57 - 49.68 | 44.53 | -60.8% |
| EV/EBITDA | 34.61 - 52.91 | 45.18 | -60.3% |
| EPV | 45.73 - 56.45 | 51.09 | -55.1% |
| DDM - Stable | 13.61 - 28.21 | 20.91 | -81.6% |
| DDM - Multi | 34.68 - 56.72 | 43.12 | -62.1% |
| Market Cap (mil) | 4,058.67 |
| Beta | 1.56 |
| Outstanding shares (mil) | 35.69 |
| Enterprise Value (mil) | 4,437.06 |
| Market risk premium | 8.31% |
| Cost of Equity | 13.36% |
| Cost of Debt | 8.50% |
| WACC | 12.70% |